Publications by authors named "Sharon Lewin"

Claim this Profile
L
Limitations and use of the Morpheus-V5 dual reporter virus in assessing interventions that target HIV latency.
Kiho Tanaka, Youry Kim, Jesslyn Ong, Carolin Tumpach, Ajantha Rhodes, Sharon R Lewin

J Virol Methods· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of acute stress on the HIV reservoir: a prospective interventional trial.
Jared Stern, Michael Roche, Rory Shepherd, Wendy Hartogensis, Patricia Moran, Sharon R Lewin

J Virus Erad· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pomalidomide enhances CD8 T and NK cell mediated killing of HIV-infected cells.
Rachel D Pascoe, Celine Gubser, J Judy Chang, Jan Schröder, Daniel T Utzschneider, Sharon R Lewin

EBioMedicine· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of analytical treatment interruptions in shaping HIV-specific immunity and HIV cure.
Mihiri Weerasuria, James H McMahon, Sharon R Lewin, Jillian S Y Lau

Curr Opin HIV AIDS· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analytical treatment interruption as a tool in the evaluation of immune-mediated interventions for long-term antiretroviral-free control of HIV-1 among people with HIV.
Ana Gabriela Pires Dos Santos, Manal Abunimeh, Beatriz Mothe, Jean-Pierre Routy, Jacob P Lalezari, Sharon R Lewin

Contemp Clin Trials· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism for evolution of diverse autologous antibodies upon broadly neutralizing antibody therapy of people with HIV.
Deepti Kannan, Eric Wang, Steven G Deeks, Sharon R Lewin, Arup K Chakraborty

Cell Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy and impact on tissue reservoirs.
Hannah A D King, Thomas A Angelovich, Michael A Moso, Rachel D Pascoe, Melissa J Churchill, Sharon R Lewin

Curr Opin HIV AIDS· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The imperative for increased investment for an HIV cure.
Remko van Leeuwen, Françoise Barré-Sinoussi, Michaela Müller-Trutwin, Asier Sáez-Cirión, Monique Nijhuis, Sharon R Lewin

Lancet HIV· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV and the gut: implications for HIV persistence, immune dysfunction and cure strategies.
Jillian S Y Lau, Sharon R Lewin, Sushama Telwatte

Front Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meeting Summary for Keystone Symposia on HIV Cure: Antiretroviral Therapy (ART)-Free Control of HIV Infection in Durban, South Africa, 2025.
Kiho Tanaka, Tatenda Jimmy Blessing Chikowore, Steven G Deeks, Jacob D Estes, Ya-Chi Ho, Sharon R Lewin

Pathog Immun· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR/Cas9 for achieving postintervention HIV control.
Michael A Moso, Michael Roche, Paula M Cevaal, Sharon R Lewin

Curr Opin HIV AIDS· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B surface antigen is upregulated by HIV Tat in an HIV-hepatitis B virus co-infection model system.
Wei Zhao, Kasha Singh, Vitini Sozzi, Paula Cevaal, Fernando J Rossello, Sharon R Lewin

Microbiol Spectr· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A timeline of reckoning: Tracking the historical rise of antimicrobial resistance across HIV, TB, and malaria.
Tayla Williamson, Jack Adderley, Kylie Quinn, Taane G Clark, Sharon R Lewin

J Glob Antimicrob Resist· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-B*15:01-positive severe COVID-19 patients lack CD8 T cell pools with highly expanded public clonotypes.
Louise C Rowntree, Lilith F Allen, Ruth R Hagen, Hayley A McQuilten, Ahmed A Quadeer, Sharon R Lewin

Proc Natl Acad Sci U S A· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Host-directed approaches in the pursuit of a cure for HIV.
Rory A Shepherd, Kiho Tanaka, Hannah A D King, Maya D Schou, Oscar H Lloyd Williams, Sharon R Lewin

Antiviral Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunities and challenges for hepatitis B cure in people living with HIV and hepatitis B virus.
Kasha P Singh, Jennifer Audsley, Wei Zhao, Sharon R Lewin

J Int AIDS Soc· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient mRNA delivery to resting T cells to reverse HIV latency.
Paula M Cevaal, Stanislav Kan, Bridget M Fisher, Michael A Moso, Abigail Tan, Sharon R Lewin

Nat Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetics and predictors of Hepatitis B surface antigen (HBsAg) loss after commencing HBV-active antiretroviral therapy (ART) in the setting of HIV-and chronic HBV co-infection.
Jennifer Audsley, Anchalee Avihingsanon, Xin Li, Rosalind Edwards, Kathy Jackson, Sharon R Lewin

Clin Infect Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pandemic research: the need for a paradigm shift.
Lin-Fa Wang, Sharon R Lewin, Nanshan Zhong, Linqi Zhang, Zhiwei Chen

Lancet Microbe· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV Tat as a latency reversing agent: turning the tables on viral persistence.
Bridget M Fisher, Paula M Cevaal, Michael Roche, Sharon R Lewin

Front Immunol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Ikaros and Aiolos with pomalidomide fails to reactivate or induce apoptosis of the latent HIV reservoir.
Rachel D Pascoe, Youry Kim, Ajantha Rhodes, Jesslyn Ong, Carolin Tumpach, Sharon R Lewin

J Virol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism for evolution of diverse autologous antibodies upon broadly neutralizing antibody therapy of people with HIV.
Deepti Kannan, Eric Wang, Steven G Deeks, Sharon R Lewin, Arup K Chakraborty

bioRxiv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target product profile for cell-based and gene-based therapies to achieve a cure for HIV.
Sharon R Lewin, Cathy Bansbach, Dominic Kemps, Lauren Mathae, Kumitaa Theva Das

Lancet HIV· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Circulating capsid-antibody-complexes (CACs) drive intrahepatic complement deposition and inform subclinical liver inflammation in chronic hepatitis B" [Antivi. Res. 231 (2024) 1-13/106017].
Yijie Tang, Mingzhu Xu, Cong Wang, Min Wu, Lyuyin Hu, Sharon R Lewin

Antiviral Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Learning from COVID-19: strengthening Australia's research capacity through preparedness and collaboration.
Miranda Z Smith, Janelle Bowden, Linda Cristine, Anthony L Cunningham, John Kaldor, Sharon R Lewin

Commun Dis Intell (2018)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis